SCHEMBL4684232

SCHEMBL4684232

Cc1cc(C(N)=O)ccc1OCCO

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.49
THRA P10827 1/20 0.45
THRB P10828 1/20 0.45
KCNH2 Q12809 2/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44
SLC6A3 Q01959 1/20 0.44
TAS1R3 Q7RTX0 1/20 0.43
TAS1R1 Q7RTX1 1/20 0.43
HTT P42858 1/20 0.43
S1PR3 Q99500 1/20 0.43
PDE4A P27815 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
PDE4D Q08499 1/20 0.43
CHEK2 O96017 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4687532 0.92 MAPK1 (0.48) MAPK1THRATHRBKCNH2SLC6A2
SCHEMBL25199161 0.87 TOP2A (0.51) MAPK1THRATHRBKCNH2SLC6A2
SCHEMBL12492815 0.85 MRGPRX4 (0.50) THRATHRBKDM4EPOLB
SCHEMBL4025985 0.84 MAPK1 (0.65) MAPK1PDE4APDE4BPDE4CPDE4D
SCHEMBL26827950 0.84 THRA (0.51) THRATHRBKCNH2TAS1R3TAS1R1
SCHEMBL25211177 0.83 MAPK1 (0.51) MAPK1THRATHRBKCNH2SLC6A2
SCHEMBL12492829 0.83 ALDH1A1 (0.55) THRATHRBTAS1R3TAS1R1S1PR3
SCHEMBL12970778 0.83 MAPK1 (0.72) MAPK1PDE4APDE4BPDE4CPDE4D
SCHEMBL4687860 0.81 MRGPRX4 (0.46) MAPK1THRATHRBKCNH2SLC6A2
SCHEMBL6305137 0.81 MAPK1 (0.45) MAPK1THRATHRBKCNH2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1805163-B1 1,1A,5,5A-TETRAHYDRO-3-THIA-CYCLOPROPA[A]PENTALENES: TRICYCLIC THIOPHENE DERIVATIVES AS S1P1/EDG1 RECEPTOR AGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2008-10-01 EP claimed
WO-2016053855-A1 SPHINGOSINE-1-PHOSPATE RECEPTOR MODULATORS FOR TREATMENT OF CARDIOPULMONARY DISORDERS THE SCRIPPS RESEARCH INSTITUTE (US) 2016-04-07 WO disclosed